Company: GIFLF
Filing Date: 2025-04-11
Form Type: 20-F
Source: 0001104659-25-034245
Chunk: 226

Company: Grifols SA
Filing Date: 2025-04-11
Form: 20-F
Item: Item 6
Chunk 226
---
 performance objectives. The CEO’s variable remuneration was determined by applying a weighted payment coefficient to each objective described above, with the final variable compensation amount reached after applying a total achievement percentage of 83.86%.

141

Executive Chairman (until September 2024)
For the year ended December 31, 2024, Mr. Thomas Glanzmann, our non-Executive Chairperson of the Board who, until September 2024, served as executive Chairperson, accrued €1.2 million as fixed remuneration and €1.1 million in variable compensation, both payable in cash. His variable remuneration was calculated based on the achievement of the abovementioned specific performance objectives. His variable remuneration was determined by applying a weighted payment coefficient to each objective described above, with the final variable compensation amount reached after applying a total achievement percentage of 90.85%.
Chief Operating Officer and Chief Corporate Officer (until May 2024)
Mr. Raimon Grifols Roura and Mr. Victor Grifols Deu received compensation for their executive functions prior to stepping down on May 31, 2024. Mr. Raimon Grifols Roura accrued a total of €3.9 million, including €455,370.78 in fixed salary and €3.3 million in additional compensation, as they were entitled to contractual severance payments pursuant to their respective employment agreements following the change in our executive management with the appointment of Mr. José Ignacio Abia Buenache as Chief Executive Officer. Similarly, Mr. Victor Grifols Deu accrued €3.9 million, composed of €455,560.08 in fixed salary and €3.3 million in additional compensation. Additionally, Mr. Raimon Grifols Roura accrued the right to receive remuneration as a member of the supervisory board of our subsidiary Biotest AG in the amount of €18,333.33.
Each of Mr. Raimon Grifols Roura and Mr. Víctor Grifols also received 21,274 restricted stock units (RSUs) allocated in fiscal year 2022, which had a vesting period of two years and one day. Hence, in 2024 each was awarded Class B shares in the amount of €115,305.08. These RSUs were granted under the terms applicable to executive directors at the time of their service in such capacity in accordance with the remuneration policy then applicable.